1.
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the...
by Murray, Christopher J L
The Lancet (British edition), 2015-11-28, Vol.386 (10009), p.2145-2191
2.
Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
by De Angelis, Roberta, MSc
The lancet oncology, 2014, Vol.15 (1), p.23-34
3.
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease St...
by Naghavi, Mohsen
The Lancet (British edition), 2015-01-10, Vol.385 (9963), p.117-171
4.
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
by Kenna, Kevin P
Neuron (Cambridge, Mass.), 2018-03-21, Vol.97 (6), p.1268-1283.e6
5.
Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients
by Wu, Na
Microbial ecology, 2013-08-01, Vol.66 (2), p.462-470
6.
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
by Rouvière, Olivier
The lancet oncology, 2019-01, Vol.20 (1), p.100-109
7.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
by Schröder, Fritz H, Prof
The Lancet (British edition), 2014, Vol.384 (9959), p.2027-2035
8.
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
by Vos, Theo, Prof
The Lancet (British edition), 2012-12-15, Vol.380 (9859), p.2163-2196
9.
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010
by Salomon, Joshua A, Prof
The Lancet (British edition), 2012, Vol.380 (9859), p.2129-2143
10.
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
by Goyal, Mayank, Prof
The Lancet (British edition), 2016, Vol.387 (10029), p.1723-1731
11.
The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study
by Cross, Marita
Annals of the rheumatic diseases, 2014-07, Vol.73 (7), p.1323-1330
12.
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
by Allemani, Claudia, PhD
The Lancet (British edition), 2015, Vol.385 (9972), p.977-1010
13.
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic anal...
by Degenhardt, Louisa
The Lancet (British edition), 2015-08-22, Vol.386 (9995), p.743-800
14.
Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged ≥60 years: a systematic review and meta-analysis
by Hupin, David
British Journal of Sports Medicine, 2015-10, Vol.49 (19), p.1262-1267
15.
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
by Fowkes, F Gerald R, Prof
The Lancet (British edition), 2013, Vol.382 (9901), p.1329-1340
16.
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
by Vos, Theo, Prof
The Lancet (British edition), 2012-12-15, Vol.380 (9859), p.2197-2223
17.
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
by Pishvaian, Michael J
The lancet oncology, 2020-04, Vol.21 (4), p.508-518
18.
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
by Carhart-Harris, R. L
Psychopharmacology, 2017-11-08, Vol.235 (2), p.399-408
19.
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 t...
by Scherpereel, Arnaud
The lancet oncology, 2019-02, Vol.20 (2), p.239-253
20.
Unstuck in time: episodic future thinking reduces delay discounting and cigarette smoking
by Stein, Jeffrey S
Psychopharmacology, 2016-08-23, Vol.233 (21-22), p.3771-3778
Filter electronic articles 303.254 Hits
Remove Filters
- Subjects
- Middle Aged
- Humans (303.230)
- Science & Technology (299.747)
- more ...